Haeyoung Suh-Kim
Overview
Explore the profile of Haeyoung Suh-Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
1055
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Choi J, Acharya R, Cha H, Lee K, Seo J, Yang E, et al.
Proc Natl Acad Sci U S A
. 2024 Nov;
121(49):e2409773121.
PMID: 39602265
encodes the alpha subunit of the heterotrimeric Go protein. Despite being the most abundant G protein at synapses, the role of Go in the brain remains unclear, primarily because of...
2.
Bashyal N, Kim M, Jung J, Acharya R, Lee Y, Hwang W, et al.
Int J Stem Cells
. 2023 Aug;
16(4):415-424.
PMID: 37643762
Therapeutic efficacy of mesenchymal stem cells (MSCs) is determined by biodistribution and engraftment . Compared to intravenous infusion, biodistribution of locally transplanted MSCs are partially understood. Here, we performed a...
3.
Kim M, Lee Y, Jung J, Chang D, Bashyal N, Suh-Kim H, et al.
Am J Cancer Res
. 2023 Jul;
13(6):2439-2451.
PMID: 37424825
Cancer immunotherapy has emerged as a promising approach for treating various malignancies. In this study, we investigated the combined therapeutic effects of mesenchymal stem cells expressing cytosine deaminase (MSC/CD) and...
4.
Lee Y, Jung J, Chang D, Kim M, Bashyal N, Hwang W, et al.
Am J Cancer Res
. 2023 Jul;
13(6):2410-2425.
PMID: 37424800
Glioblastoma multiforme (GBM) is a highly aggressive brain tumor with poor prognosis and limited treatment options. While 5-fluorouracil (5-FU) has not been widely employed in GBM therapy, emerging research indicates...
5.
Bashyal N, Lee Y, Jung J, Kim M, Lee K, Hwang W, et al.
Int J Stem Cells
. 2023 Jun;
16(4):438-447.
PMID: 37385638
Recently, gene therapy has emerged as a promising approach to enhance the therapeutic potential of mesenchymal stem cells (MSCs) by introducing functional genes . Here, we explored the need of...
6.
Bashyal N, Lee T, Chang D, Jung J, Kim M, Acharya R, et al.
Mol Cells
. 2022 Mar;
45(7):479-494.
PMID: 35356894
Human mesenchymal stem cells (MSCs) are multipotent stem cells that have been intensively studied as therapeutic tools for a variety of disorders. To enhance the efficacy of MSCs, therapeutic genes...
7.
Choi J, Acharya R, Marasini S, Narayan B, Lee K, Hwang W, et al.
Exp Neurobiol
. 2021 Jul;
30(3):203-212.
PMID: 34230222
The inducible system provides a useful tool for inducing the selective deletion of genes that are essential for proper development and enables the study of gene functions in properly developed...
8.
Lee T, Cho I, Bashyal N, Naya F, Tsai M, Yoon J, et al.
Exp Neurobiol
. 2020 Jul;
29(3):189-206.
PMID: 32606250
Neurogenic differentiation 1 (NeuroD1) is a class B basic helix-loop-helix (bHLH) transcription factor and regulates differentiation and survival of neuronal and endocrine cells by means of several protein kinases, including...
9.
Han J, Yoon J, Chang D, Cho K, Lim J, Kim S, et al.
Mol Cells
. 2020 Jun;
43(6):539-550.
PMID: 32597394
Glioblastoma multiforme (GBM) is a fatal malignant tumor that is characterized by diffusive growth of tumor cells into the surrounding brain parenchyma. However, the diffusive nature of GBM and its...
10.
Chang D, Jung J, Kim A, Marasini S, Lee Y, Paek S, et al.
Am J Cancer Res
. 2020 Jun;
10(5):1429-1441.
PMID: 32509389
Glioblastoma multiforme (GBM) is the most common and aggressive primary brain tumor, and current standard therapy provides modest improvements in progression-free and overall survival of patients. Innate tumor resistance and...